Medical Xpress January 10, 2025
Weill Cornell Medical College

Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to medicines for most patients in the United States—steer patients to use their own pharmacies. However, these pharmacies appear less used in Medicare than in other market segments. These PBMs are part of integrated health care conglomerates that own insurance companies and pharmacies, which may create conflicts of interest.

The study, published Jan. 10 in JAMA Health Forum, found that in 2021 a third of all Medicare Part D spending and almost 40% of specialty drug spending within Medicare Part D was through pharmacies owned by the four largest PBMs: CVS, UnitedHealth Group, Cigna or Humana.

However, this represents a far lower market share in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare, Pharma, Pharma / Biotech, Survey / Study, Trends
Drug Price Negotiation Requires Oversight To Protect Older Americans
Prices of 25 Medicare Part D drugs up 98%
Podcast: The Scope of Medicare Fraud
Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs
Harnessing AI to reduce Medicare errors, improve accuracy, and ease physician burnout

Share This Article